Propanc Biopharma, Inc. – OTC:PPCB
Propanc Biopharma stock price today
$4.13
+4.12
+2064650%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Propanc Biopharma stock price monthly change
-100.00%
month
Propanc Biopharma stock price quarterly change
-100.00%
quarter
Propanc Biopharma stock price yearly change
-100.00%
year
Propanc Biopharma key metrics
Market Cap | 355.89K |
Enterprise value | 1.14M |
P/E | -0.05 |
EV/Sales | N/A |
EV/EBITDA | -0.60 |
Price/Sales | N/A |
Price/Book | -0.16 |
PEG ratio | N/A |
EPS | -7.59 |
Revenue | N/A |
EBITDA | -1.59M |
Income | -2.98M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePropanc Biopharma stock price history
Propanc Biopharma stock forecast
Propanc Biopharma financial statements
| Jun 2022 | 0 | -904.76K | |
|---|---|---|---|
| Mar 2023 | 0 | -809.80K | |
| Jun 2023 | 0 | -748.04K | |
| Mar 2024 | 0 | -526.7K |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2020 | |
|---|---|
| 2021 | 249.86% |
| 2022 | 278.97% |
| 2023 | 198.64% |
| 2024 |
| Dec 2022 | 108022 | 3.02M | 2798.91% |
|---|---|---|---|
| Mar 2023 | 143742 | 3.08M | 2146.31% |
| Jun 2023 | 60328 | 3.17M | 5267.05% |
| Mar 2024 | 37337 | 3.73M | 10008.45% |
| Jun 2022 | -410.99K | 0 | 374.28K |
|---|---|---|---|
| Mar 2023 | -192.73K | 0 | 269.5K |
| Jun 2023 | -177.97K | 0 | 100K |
| Mar 2024 | -106.22K | 0 | 70.26K |
Propanc Biopharma alternative data
| Sep 2023 | 1 |
|---|---|
| Oct 2023 | 1 |
| Nov 2023 | 1 |
| Dec 2023 | 1 |
| Jan 2024 | 1 |
| Feb 2024 | 1 |
| Mar 2024 | 1 |
| Apr 2024 | 1 |
| May 2024 | 1 |
| Jun 2024 | 1 |
| Jul 2024 | 1 |
Propanc Biopharma other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2012 | 250000 | 0 |
| Sep 2012 | 0 | 255000 |
| Dec 2012 | 0 | 5500 |
| Jan 2013 | 0 | 15000 |
| Jul 2013 | 0 | 55000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | NATHANIELSZ JAMES ANDREW director, 10 perc.. | Common stock, par value $0.001 per share | 55,000 | $0.09 | $5,005 | ||
Sale | NATHANIELSZ JAMES ANDREW director, 10 perc.. | Common stock, par value $0.001 per share | 15,000 | $0.2 | $3,000 | ||
Sale | NATHANIELSZ JAMES ANDREW director, 10 perc.. | Common stock, par value $0.001 per share | 5,500 | $0.2 | $1,100 | ||
Sale | NATHANIELSZ JAMES ANDREW director, 10 perc.. | Common stock, par value $0.001 per share | 5,000 | $0.2 | $1,000 | ||
Sale | NATHANIELSZ JAMES ANDREW director, 10 perc.. | Common stock, par value $0.001 per share | 250,000 | $0.2 | $50,000 | ||
Purchase | NATHANIELSZ JAMES ANDREW director, 10 perc.. | Common Stock | 250,000 | $0.2 | $50,000 |
-
What's the price of Propanc Biopharma stock today?
One share of Propanc Biopharma stock can currently be purchased for approximately $4.13.
-
When is Propanc Biopharma's next earnings date?
Unfortunately, Propanc Biopharma's (PPCB) next earnings date is currently unknown.
-
Does Propanc Biopharma pay dividends?
No, Propanc Biopharma does not pay dividends.
-
How much money does Propanc Biopharma make?
Propanc Biopharma has a market capitalization of 355.89K.
-
What is Propanc Biopharma's stock symbol?
Propanc Biopharma, Inc. is traded on the OTC under the ticker symbol "PPCB".
-
What is Propanc Biopharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Propanc Biopharma?
Shares of Propanc Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Propanc Biopharma's key executives?
Propanc Biopharma's management team includes the following people:
- Mr. James Nathanielsz Executive Chairman, Chief Executive Officer, Chief Financial Officer, Treasurer & Sec.(age: 51, pay: $541,290)
- Dr. Julian Norman Kenyon Chief Scientific Officer & Director(age: 77, pay: $40,530)
-
How many employees does Propanc Biopharma have?
As Jul 2024, Propanc Biopharma employs 1 workers.
-
When Propanc Biopharma went public?
Propanc Biopharma, Inc. is publicly traded company for more then 12 years since IPO on 12 Nov 2012.
-
What is Propanc Biopharma's official website?
The official website for Propanc Biopharma is propanc.com.
-
Where are Propanc Biopharma's headquarters?
Propanc Biopharma is headquartered at 302, 6 Butler Street, Camberwell, VIC.
-
How can i contact Propanc Biopharma?
Propanc Biopharma's mailing address is 302, 6 Butler Street, Camberwell, VIC and company can be reached via phone at +61 3 9882 0780.
Propanc Biopharma company profile:
Propanc Biopharma, Inc.
propanc.comExchange:
OTC
Full time employees:
1
Industry:
Biotechnology
Sector:
Healthcare
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
302, 6 Butler Street
Camberwell, VIC 3124
Camberwell, VIC 3124
CIK: 0001517681
ISIN: US74346N4043
CUSIP: 74346N404
